October 2021 - Page 12 of 31

WednesdayOct 20, 2021 12:52 pm

DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) CryptoHawk Solution Empowers Traders to Maximize Returns with AI

DigiMax’s CryptoHawk is an effective way for crypto traders to harness the power of AI CryptoHawk meets the needs of casual, serious and professional cryptocurrency traders CryptoHawk is a subscription offering of real-time predictions, trades and market depth for cryptocurrencies In a world where artificial intelligence (“AI”) is now part of our lives, crypto trading is no exception. In fact, DigiMax Global (CSE: DIGI) (OTC: DBKSF) offers CryptoHawk, a subscription service capable of predicting cryptocurrency trends. Research shows that investors who use AI can improve their ability to generate alpha returns. In the U.S. stock market and other development financial…

WednesdayOct 20, 2021 12:49 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Commences Digital Campaign to Promote Brand, Make Fan Pass a Household Name

Friendable (OTC: FDBL), a mobile technology and marketing company, recently released 15- and 30-second radio spots on Spotify and other programmatic networks as part of its 120-day strategy, which also included the release of version 2.0 of the Fan Pass platform. Following the release of the all-new version, Friendable took the necessary steps to ensure a stable platform and sound service offerings. “Now, it’s time to begin promoting our brand and mission with the release of these two radio spots, which are just beginning to run on various networks including Spotify,” a recent article quotes Friendable CEO Robert A. Rositano…

WednesdayOct 20, 2021 12:16 pm

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Validation of Pre-Harvest Applications of Its Treatments by Leading California Academic Institution

Save Foods (NASDAQ: SVFD), an Israeli-based agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced the completion of a series of successful trials in conjunction with a leading California academic institution. Save Foods is collaborating with several plant pathologists and researcher labs as part of its efforts to validate the efficacy of its products. Recently, a world-renowned academic institution in California validated the efficacy and impact of Save Foods’ treatments as a pre-harvest application. Results from the study demonstrate pre-harvest applications…

WednesdayOct 20, 2021 12:03 pm

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Intent on Uplisting to TSX; Opens Brick-and-Mortar Store in Squamish, BC

The company will remain a part of the Canadian Securities Exchange (VEGA), the US OTCQB market (PLTXF), and the Frankfurt Exchange (WNT1) The October 14 opening of XMarket, a brick-and-mortar store in Squamish, British Columbia, offered the community the opportunity to experience plant-based products, educational opportunities and partake in local business offerings Devoted to spreading awareness of plant-based living, PlantX offers consumers various educational resources such as a weekly podcast, a YouTube channel featuring recipe videos and the company’s Taste This! Series, and the company’s website blog PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is on a mission to…

WednesdayOct 20, 2021 11:05 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Reveals Effectiveness of Proprietary Drug-Development Tech

Lexaria Bioscience (NASDAQ: LEXX), developers of the revolutionary DehydraTECH(TM) drug-delivery technology, has released study results focused on THC-A21-1, a THC oral format. According to the announcement, the study showed that Lexaria’s DehydraTECH THC solution delivers THC levels to blood plasma an estimated three times faster than standard MCT-based THC. Based on study results, it took only 15 minutes using oral ingestion of the substance to reach THC levels comparable to those reached in 45 minutes using "coconut-oil" formulations. As the THC left the system at the six-hour mark, levels were comparable and demonstrated the fast-on, fast-off performance. The DehydraTECH results are timely…

WednesdayOct 20, 2021 10:33 am

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Granted Approval to Evaluate Sensory Factors in Product-Development Trials

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has received an amendment to a cannabis research license it had previously been granted by Health Canada. The amendment allows the company to include sensory evaluations of cannabis beverages in an upcoming product development trial. According to the announcement, the company will be able to conduct onsite human assessments of the taste, smell, feel and visual appeal of products the company is developing, a move that BevCanna says will provide significant advantages for its white-label clients as well as in-house brands because the new-product trial capabilities are unique in the Canadian cannabis beverage…

WednesdayOct 20, 2021 9:26 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to Revolutionizing the Nicotine Industry with its Alternative Nicotine Delivery

Lexaria’s recent animal study on its patented DehydraTECH(TM) technology on nicotine absorption yielded ground-breaking results This study builds on an earlier 2018 study that demonstrated effective delivery of nicotine to the central nervous system in a rodent study The study’s success will serve as the foundation for a human trial that will compare the DehydraTECH-nicotine pouch performance to leading brands Zacks Small Cap Research recently did a deep dive on Lexaria Bioscience (NASDAQ: LEXX) and its contribution to alternative nicotine delivery. Its evaluation acknowledged that the global tobacco market is currently valued at $818 billion, mainly sustained by over 1.1…

TuesdayOct 19, 2021 3:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Impacting the Pharmaceutical Industry

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to enhancing the speed and overall efficiency of orally delivered fat-soluble active molecules. The company is leveraging its drug delivery technology, DehydraTECH(TM), in the development of hypertension and anti-viral treatments — a big achievement already making an impact in the pharmaceutical industry. “Since Lexaria began working on this technology in 2014, DehydraTECH has developed considerably and impacted the industry. So far, it has proven useful for potentially treating hypertension, along with the delivery of colchicine, a drug with known SARS-CoV-2 anti-viral properties,” reads a recent article. “DehydraTECH is applied by incorporating an…

TuesdayOct 19, 2021 2:36 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Bringing Leading US Beverage Brands to Canadian Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, is developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The company has sought to capitalize on the growing demand, most recently through its various collaborations with U.S. cannabis-infused beverage manufacturers. Strong growth trends of the cannabis-derived drinks market in the U.S. look promising for the nascent Canadian sector, which is poised for significant growth in the coming months and years. “A key driver set to underpin future growth within the…

TuesdayOct 19, 2021 2:20 pm

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS), Candid to Bring Airway and Sleep, Oral Health, Orthodontic Therapy Together in Comprehensive Solution

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring, and Candid Care Co., a digital platform for oral healthcare, have announced a new collaboration. Under the partnership, the companies will seek to provide patients with a comprehensive, whole-mouth solution to diagnose and treat OSA in adult patients and provide orthodontic treatment from the same provider network. Additionally, under the agreement, Vivos and Candid will join forces to explore new research and development opportunities for device development and other alliances related to…

Site Search

Company Search

Month: October 2021